Ori Biotech Raises Over $100 Million In Series B Funding To Launch Innovative Cell And Gene Therapy Manufacturing Platform
Amount Raised
$100 Million
Round Type
Series B
LondonSoftwareData And AnalyticsScience And EngineeringDescription
Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has secured over $100 million in an oversubscribed Series B funding round. The investment round was led by Novalis LifeSciences with Puhua Capital and Chimera Abu Dhabi coming in as new investors. Existing investors from Ori's $30 million Series A round in 2020, including Amadeus Capital Partners, Delin Ventures, Northpond Ventures and Octopus Ventures, have continued to support the company with additional funding.
Quick answer
Ori Biotech raised $100 Million in a Series B round, dated January 18, 2022. Ori Biotech is based in London, England, United Kingdom.
- How much did Ori Biotech raise?
- Ori Biotech raised $100 Million in a Series B round on January 18, 2022.
- What does Ori Biotech do?
- Ori is a London-and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies.
- Where is Ori Biotech based and how big is it?
- Ori Biotech is based in London, England, United Kingdom. Fundz records about 85 employees.
- Who are the decision-makers at Ori Biotech?
- Fundz holds 2 contacts at Ori Biotech, including the Founder and Chief Scientific Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as Ori Biotech that raised within 45 days of this round, from Fundz verified event records.
- Inworld AI raised an undisclosed amount on March 4, 2022.
- ArrePath raised $20M (Seed) on March 3, 2022.
- EdgeCortix raised an undisclosed amount (Series A) on March 1, 2022.
- RIOS raised $28M (Series A) on February 24, 2022.
- Bloomreach raised $175M on February 23, 2022.
- GreenScreens AI, Inc. raised an undisclosed amount on February 22, 2022.
Who to call at Ori Biotech, and when
A new round usually means Ori Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ori Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ori Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ori Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ori Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOri Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.